Trial intelligence / Profile preview

SiFICB vs Tramadol for Preoperative Analgesia in Hip Fracture

NCT06728033Not yet recruiting

Sponsor
West China Hospital of Sichuan University
Start
Jan 2025
Primary completion
May 2027
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
Countries
1
01

Overview

Randomised trial of ropivacaine hydrochloride liposomal suspension injection in hip fracture (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Resting numerical rating scale (NRS) pain scores preoperatively. Planned start Jan 2025; status: not yet recruiting.

02

Drugs

ropivacaine hydrochloride liposomal suspension injection
03

Conditions

hip fracture

Beyond the preview

Go deeper on NCT06728033.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06728033.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call